Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (SHA:603896)

China flag China · Delayed Price · Currency is CNY
21.87
-0.18 (-0.82%)
Jul 28, 2025, 2:43 PM CST
-0.82%
Market Cap4.37B
Revenue (ttm)641.59M
Net Income (ttm)155.96M
Shares Out198.24M
EPS (ttm)0.78
PE Ratio28.19
Forward PE23.97
Dividend0.27 (1.22%)
Ex-Dividend DateJun 6, 2025
Volume3,003,196
Average Volume2,570,526
Open22.05
Previous Close22.05
Day's Range21.84 - 22.30
52-Week Range18.22 - 27.13
Beta0.37
RSI60.50
Earnings DateAug 28, 2025

About SHA:603896

Zhejiang Shouxiangu Pharmaceutical Co., Ltd. researches, develops, and sells Chinese medicine products. It offers ganoderma lucidum spore powder, dendrobium officinale and ganoderma lucidum extract, dendrobium officinale granules, saffron extract, crocus sativus, and other health products. Zhejiang Shouxiangu Pharmaceutical Co., Ltd. was founded in 1997 and is based in Jinhua, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1997
Employees 1,118
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603896
Full Company Profile

Financial Performance

In 2024, SHA:603896's revenue was 691.68 million, a decrease of -11.81% compared to the previous year's 784.35 million. Earnings were 174.71 million, a decrease of -31.34%.

Financial Statements

News

There is no news available yet.